Spots Global Cancer Trial Database for oligometastatic
Every month we try and update this database with for oligometastatic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment | NCT01796288 | Non Small Cell ... | simultaneous ra... Erlotinib | 18 Years - 80 Years | Wu Jieping Medical Foundation | |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | NCT06430411 | Prostate Cancer... Prostate Cancer... Prostate Cancer Prostate Neopla... Oligometastatic... Oligometastasis | Radical prostat... Prostate irradi... Surgical metast... Irradiation of ... Abiraterone ace... Enzalutamide Darolutamide Apalutamide Docetaxel Lutetium-PSMA Androgen depriv... | 18 Years - 80 Years | Medical University of Vienna | |
| SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy | NCT05990192 | Ovarian Cancer ... | Niraparib oral ... SBRT | 18 Years - | Institute of Cancer Research, United Kingdom | |
| Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer | NCT02417662 | Non-small Cell ... | Radical Radioth... Non-investigati... | 18 Years - | University College, London | |
| SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy | NCT05990192 | Ovarian Cancer ... | Niraparib oral ... SBRT | 18 Years - | Institute of Cancer Research, United Kingdom | |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | NCT06430411 | Prostate Cancer... Prostate Cancer... Prostate Cancer Prostate Neopla... Oligometastatic... Oligometastasis | Radical prostat... Prostate irradi... Surgical metast... Irradiation of ... Abiraterone ace... Enzalutamide Darolutamide Apalutamide Docetaxel Lutetium-PSMA Androgen depriv... | 18 Years - 80 Years | Medical University of Vienna | |
| Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer | NCT03298087 | Newly Diagnosed... | radical prostat... stereotactic bo... Leuprolide apalutamide abiraterone | 18 Years - | VA Office of Research and Development | |
| Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer | NCT06299852 | HER2-positive M... Oligometastatic... | Trastuzumab emt... | 18 Years - | N.N. Petrov National Medical Research Center of Oncology | |
| Local Consolidative Therapy in Colorectal Cancer | NCT05062720 | Colorectal Canc... | Local consolida... | 18 Years - | Fox Chase Cancer Center | |
| Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma | NCT01565837 | Melanoma | Ipilimumab Stereotactic Ab... | 18 Years - | Comprehensive Cancer Centers of Nevada | |
| A Randomized Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II) | NCT01965223 | Cancer Metastases to t... | Multi-fraction ... Single Fraction... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| 5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases | NCT01761929 | Solid Tumors Wi... | Radiation: 50Gy... | 18 Years - | University Health Network, Toronto | |
| 5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases | NCT01761929 | Solid Tumors Wi... | Radiation: 50Gy... | 18 Years - | University Health Network, Toronto | |
| The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC） | NCT02076477 | Oligo-metastati... | concurrent chem... Docetaxel pemetrexed Cisplatin | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer | NCT03298087 | Newly Diagnosed... | radical prostat... stereotactic bo... Leuprolide apalutamide abiraterone | 18 Years - | VA Office of Research and Development |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
